BioCentury
ARTICLE | Company News

PregLem, Merck KGaA deal

August 16, 2010 7:00 AM UTC

Merck's Merck Serono S.A. unit granted PregLem exclusive, worldwide rights to develop and commercialize bentamapimod. Merck will receive an upfront payment and is eligible for milestones and royalti...